Innventure Inc (INV) Stock News

Block & Leviton is investigating CVRx, Inc., Papa John's International, and HubSpot for potential securities fraud. CVRx cut its revenue guidance citing sales force challenges and reimbursement issues, while HubSpot experienced a 25% share price decline. Investors who have suffered losses are encouraged to contact the firm.

A class action lawsuit has been filed against Capricor Therapeutics for allegedly making false statements regarding changes to its statistical analysis plan for the Deramiocel drug candidate without FDA approval. The FDA's briefing documents revealed concerns about the integrity of the clinical data analysis, leading to a 64% stock price decline on July 27, 2026, followed by a 36% decline after an advisory committee voted against the drug's efficacy on July 29, 2026.

Rosen Law Firm has filed a class action lawsuit against Alarum Technologies Ltd. (NASDAQ: ALAR) on behalf of investors who purchased securities between March 20, 2025 and July 2, 2026. The lawsuit alleges that defendants made false and misleading statements regarding a subsidiary's illegal activity of linking customer home internet devices into another network without consent, which heightened legal exposure and threatened business prospects. Investors who purchased during the class period may be entitled to compensation.

Rosen Law Firm has filed a class action lawsuit against DNOW Inc. on behalf of shareholders, alleging that defendants made false and misleading statements regarding the challenges of DNOW's merger with MRC Global Inc., specifically related to material issues with MRC Global's enterprise resource planning system. Investors who held DNOW common stock as of August 5, 2025 may be eligible for compensation. The deadline to serve as lead plaintiff is October 2, 2026.

Rosen Law Firm is urging investors who purchased Photronics securities between December 10, 2025 and May 27, 2026 to join a class action lawsuit. The lawsuit alleges that Photronics made materially false statements about its high-end product pipeline and customer demand, while concealing a critical bottleneck in its design release pipeline that made forward growth expectations unachievable. The lead plaintiff deadline is September 4, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Microvast Holdings (MVST) between April 1, 2025 and March 16, 2026 to join a class action lawsuit. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and delays in the Huzhou Phase 3.2 expansion. The lead plaintiff deadline is September 21, 2026. Similar class action notices are being issued for PROCEPT BioRobotics and TransMedics Group.

Rosen Law Firm has filed class action lawsuits against Datavault AI Inc. (DVLT), Planet Fitness, Inc. (PLNT), and Erasca, Inc. (ERAS) on behalf of investors who purchased securities during specified periods. The lawsuits allege materially false and misleading statements, including overstated partnerships, inflated trading volumes, and undisclosed connections to convicted felons. Investors have until October 5, 2026 to move the court to serve as lead plaintiff.

A securities class action lawsuit has been filed against Erasca, Inc. and its executives for allegedly making false and misleading statements about its lead oncology drug candidate ERAS-0015. The company is accused of improperly comparing its drug to a competitor's candidate and failing to disclose patent and trade secret disputes. Investors who purchased Erasca stock between January 14, 2025 and April 26, 2026 must act by August 10, 2026 to serve as lead plaintiff.

Law firm Bragar Eagel & Squire is investigating Myriad Genetics for potential securities violations following the company's disappointing Q2 2026 earnings report. Myriad reported revenue of $190.7 million, down 11% year-over-year and significantly below consensus estimates. The company slashed full-year 2026 revenue guidance from $860-$880 million to $770-$790 million and suspended EBITDA guidance, citing reimbursement pressure, collection issues, and weak prenatal performance. This represents a dramatic $90 million midpoint cut just three months after reiterating prior guidance in May 2026.

A securities class action lawsuit has been filed against Nano-X Imaging Ltd. (NNOX) for allegedly making false and misleading statements about operational efficiency and product demand. The lawsuit claims the company overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses, cash burn, and the need for disruptive restructuring measures. Investors with losses exceeding $100,000 are encouraged to join the class action before the August 11, 2026 deadline.

A class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025 and July 26, 2026. The lawsuit alleges that Capricor made materially false statements regarding changes to its statistical analysis plan for Deramiocel without FDA agreement, creating significant regulatory approval risks. Investors who purchased during this period may be entitled to compensation.

A class action lawsuit has been filed against Bloom Energy Corporation on behalf of investors who purchased securities between February 27, 2025 and July 8, 2026. The lawsuit alleges that Bloom Energy made materially false and misleading statements regarding its sourcing of scandium, claiming the company obtained the metal through intermediaries from China while misrepresenting its supply chain independence. Investors who purchased during this period may be eligible for compensation.

A class action lawsuit has been filed against Wix.com Ltd. for allegedly making false statements about its AI product offerings, overstating competitiveness and performance while understating development costs. The lawsuit covers investors who purchased Wix securities between February 19, 2025 and May 12, 2026. Multiple analyst downgrades and disappointing earnings reports triggered significant stock price declines, with the stock falling over 27% following Q1 2026 results that revealed weakness in the professional developer business and competitive challenges.

Rosen Law Firm is soliciting investors who purchased securities during specified periods to join class action lawsuits. The primary case involves Hertz Global Holdings, where defendants allegedly made false statements about liquidity, used-car market conditions, and financial position, leading to a dilutive capital raise that harmed shareholders. Additional class actions are mentioned for GPGI, Inc. and Alarum Technologies Ltd.

A securities class action lawsuit has been filed against Black Rock Coffee Bar, Inc. for allegedly making materially false statements in its IPO registration statement and throughout the Class Period (September 12, 2025 - May 12, 2026). The lawsuit claims defendants failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results. Investors with losses exceeding $100K are encouraged to join the class action before the August 17, 2026 lead plaintiff deadline.

Rosen Law Firm announces a securities class action lawsuit against Roblox Corporation, alleging the company made materially false and misleading statements about its organic growth potential. The lawsuit claims Roblox concealed that age verification rollout would cause significant growth slowdown, reduced on-platform communication, and declining app store ratings. The lead plaintiff deadline is August 7, 2026.

Rosen Law Firm has filed a class action lawsuit against Rackspace Technology, Inc. (NASDAQ: RXT) on behalf of investors who purchased securities between May 7, 2026 and July 8, 2026. The lawsuit alleges that Rackspace made false and misleading statements regarding its enterprise AI efforts, declining Public Cloud revenue, and the impact on fiscal year 2026 revenue. Investors who wish to serve as lead plaintiff must file by September 28, 2026.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Microvast Holdings, with allegations that the company made false statements about margin targets and the Huzhou Phase 3.2 expansion completion timeline. The lead plaintiff deadline is September 21, 2026. Similar notices are being issued for Hub Group and Peabody Energy.

A securities class action lawsuit has been filed against Hub Group, Inc. (NASDAQ: HUBG) for allegedly making false and misleading statements regarding financial results. The lawsuit claims Hub Group's financial statements from Q1 2023 through Q3 2025 contained material misstatements related to revenue recognition, operating income, and expense reporting. Investors who purchased securities during the class period (April 28, 2023 - May 11, 2026) may be eligible for compensation. The deadline to serve as lead plaintiff is August 28, 2026.

ADMA Biologics is facing a securities class action lawsuit alleging the company made false statements regarding undisclosed related party transactions, channel stuffing schemes, and inadequate internal controls. A Culper Research report claimed ADMA's reported 20% growth in 2025 was artificially inflated, with actual revenue declining 3% when adjusted for extended payment terms. The stock declined over 16% following the report, and an additional 13% after a Cantor Fitzgerald downgrade. Investors with substantial losses can seek lead plaintiff status by Monday, August 10, 2026.

Hub Group (NASDAQ: HUBG) is facing a securities class action lawsuit for allegedly making false and misleading statements about its financial reporting, including premature revenue recognition and understatement of transportation costs. The company revealed in February 2026 that it had understated costs by $77 million and later disclosed that 2023 and 2024 financial reports were also materially misstated. These disclosures resulted in stock drops totaling over $870 million in market capitalization. Investors who purchased shares between April 28, 2023, and May 11, 2026, can seek lead plaintiff status by August 28, 2026.

Law firm Kirby McInerney LLP is investigating Myriad Genetics for potential securities fraud following the company's July 30, 2026 earnings report. Myriad reported an 11% year-over-year revenue decline to $190.7 million, reduced full-year guidance, and an $11 million revenue adjustment. Hereditary cancer testing revenue fell 13% despite volume growth, attributed to lower reimbursement and unfavorable estimate changes. Management acknowledged delayed engagement with payers regarding authorization and denial issues. The stock declined 47% to $2.86 on July 31, 2026.

Law firm Kirby McInerney LLP is investigating Hims & Hers Health following an FTC lawsuit alleging the company engaged in deceptive privacy practices by sharing customers' sensitive medical information with third-party advertisers including Meta Platforms. The announcement triggered a 14.73% stock price decline on July 29, 2026.

Law firm Kirby McInerney LLP is investigating potential securities fraud claims against Dr. Reddy's Laboratories following the company's disclosure of a ₹2.4 billion provision for out-of-spec semaglutide batches in Q1 FY2027 earnings. The stock fell 9% on the news, though management stated there was no patient safety impact or regulatory filing impact.

Law firm Holzer & Holzer, LLC announced an investigation into Taboola.com Ltd. regarding potential federal securities law violations. On August 5, 2026, Taboola revised its fiscal year 2026 revenue guidance and reported Q2 2026 results that missed consensus estimates for both GAAP EPS and revenue, resulting in a stock price decline.

Rosen Law Firm has filed class action lawsuits against Pentair plc, First Solar, Inc., and Erasca, Inc. on behalf of investors who suffered losses. The Pentair lawsuit alleges the company made false statements about its business while concealing significant inventory destocking in the Pool channel that adversely affected sales and operating income. Investors with losses exceeding $100,000 are encouraged to join the class actions before upcoming deadlines.

Suja Life, Inc. announced second quarter 2026 results showing a significant 391% increase in net loss to $27.8 million, driven by IPO-related transaction costs and debt extinguishment losses. The company also revised its full-year 2026 outlook downward, citing near-term softness in the grocery channel. The stock price declined following the announcement, prompting a securities investigation.

A class action lawsuit has been filed against Rackspace Technology (RXT) for securities purchased between May 7, 2026 and July 8, 2026. The lawsuit alleges that Rackspace misrepresented its enterprise AI efforts, which would require significant reallocation of resources from its profitable Private Cloud segment, while its Public Cloud revenue was declining due to customer migration to hyperscale platforms. These factors would materially impact fiscal year 2026 revenue.

Rosen Law Firm is urging investors who purchased EquipmentShare.com Inc securities during its January 2026 IPO or between January 23 and June 23, 2026 to join a securities class action lawsuit. The lawsuit alleges that EquipmentShare made materially false statements and failed to disclose undisclosed related party transactions with entities owned by co-founders, resulting in misleading financial statements. The lead plaintiff deadline is September 21, 2026.

Shareholder class action lawsuits have been filed against Blaize Holdings, Inc. for allegedly making false statements about business transactions and improperly recognizing revenue. The lawsuit covers investors who purchased shares between July 18, 2025 and April 28, 2026. Additionally, Holzer & Holzer, LLC announced an investigation into AdaptHealth Corp. regarding potential federal securities law violations.